BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 335871)

  • 1. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
    Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
    Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase-positive B cell lymphomas.
    Abe M; Nozawa Y; Wachi E; Tominaga K; Hojo H; Wakasa H
    Eur J Haematol; 1988 Sep; 41(3):223-9. PubMed ID: 3053240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaline phosphatase positive lymphomas: a morphologic, immunologic, and enzymehistochemical study.
    Poppema S; Elema JD; Halie MR
    Cancer; 1981 Mar; 47(6):1303-12. PubMed ID: 6971701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkaline phosphatase positive lymphoma.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    Dermatologica; 1984; 169(6):342-7. PubMed ID: 6335434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
    Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
    Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia.
    Pangalis GA; Yataganas X; Fessas P
    J Clin Pathol; 1977 Sep; 30(9):812-6. PubMed ID: 303244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme histochemical characteristics of non-Hodgkin's lymphomas.
    Harigaya K
    Acta Pathol Jpn; 1977 May; 27(3):345-58. PubMed ID: 144406
    [No Abstract]   [Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase activity in malignant lymphomas.
    Donlon JA; Jaffe ES; Braylan RC
    N Engl J Med; 1977 Sep; 297(9):461-4. PubMed ID: 301987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic beta-glucuronidase in the lymphoproliferative syndromes.
    Zittoun R; Cadiou M; Dao C; Blanc JM; Bousser J
    Biomedicine; 1973 Sep; 18(5):515-20. PubMed ID: 4201753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classiciation of non-Hodgkin's lymphomas of childhood (author's transl)].
    Lennert K
    Klin Padiatr; 1977 Jan; 189(8):7-13. PubMed ID: 320375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.
    Isaacson P; Wright DH; Jones DB
    Cancer; 1983 Jan; 51(1):80-91. PubMed ID: 6336974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.